These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1513 related items for PubMed ID: 26386489

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG, Kirsztajn GM.
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [Abstract] [Full Text] [Related]

  • 3. Thrombotic microangiopathies.
    Rosove MH.
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [Abstract] [Full Text] [Related]

  • 4. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B, Einav Y.
    Autoimmun Rev; 2014 Jun; 13(4-5):584-6. PubMed ID: 24418304
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C, Stapenhorst L, Simon T, Budde U, Schneppenheim R, Hoppe B.
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.
    Tsai HM.
    Transfus Med Rev; 2014 Oct; 28(4):187-97. PubMed ID: 25280590
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic approach to microangiopathic hemolytic disorders.
    Kottke-Marchant K.
    Int J Lab Hematol; 2017 May; 39 Suppl 1():69-75. PubMed ID: 28447417
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
    Nakayama S, Hirashio S, Yorishima H, Doi T, Yoshida Y, Matsumoto M, Masaki T.
    CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
    [Abstract] [Full Text] [Related]

  • 17. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H, Matsumoto T, Yamashita Y.
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.